Biomanufacturing startup Debut Biotech raises $22.6M

2021-08-17

Debut Biotech, a startup that developed technology for cell-free enzyme-based biomanufacturing, raised $22.6 million in a Series A funding round. With the new capital, the company plans to build a 26,000-square-foot biomanufacturing facility in San Diego.

Full story:

AIChE SmartBrief

Chemical engineering news

Designed specifically for chemical engineers, AIChE SmartBrief is a FREE weekly e-mail newsletter. It helps chemical engineers stay informed on the business and technology developments affecting our profession.